RE:RE:RE:Gilles must go, along with JeneneCan't disagree with newday ... for all the apparent potential, Ceapro continues to be a major disappointment.. They need some new blood or maybe another company ... with competent Management to buy them out.
Was anyone at their Annual Meeting? Based on the NR, very little transpired !